ArticlePloS one2024
RETRACTED: Automated brain tumor diagnostics: Empowering neuro-oncology with deep learning-based MRI image analysis.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- Retraction: Automated brain tumor diagnostics: Empowering neuro-oncology with deep learning-based MRI image analysis.PloS one · 2026Article
- Enhanced brain tumor segmentation in medical imaging using multi-modal multi-scale contextual aggregation and attention fusion.Scientific reports · 2025Article
- Enhanced image registration based brain tumour segmentation using optical particle swarm intelligence technique with Resnet Inceptionv2 HCNN.Scientific reports · 2025Article
- Article
Corrections and comments
- Retraction · 2026-07-16Cites Retracted Work · Concerns/Issues about Peer Review · Euphemisms for Plagiarism · Objections by Author(s) · Plagiarism of/in Article ·
- Retracted
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors, characterized by the uncontrolled growth of abnormal cells, pose a significant threat to human health. Early detection is crucial for successful treatment and improved patient outcomes. Magnetic Resonance Imaging (MRI) is the primary diagnostic tool for brain tumors, providing detailed visualizations of the brain's intricate structures. However, the complexity and variability of tumor shapes and locations often challenge physicians in achieving accurate tumor segmentation on MRI images. Precise tumor segmentation is essential for effective treatment planning and prognosis. To address this challenge, we propose a novel hybrid deep learning technique, Convolutional Neural Network and ResNeXt101 (ConvNet-ResNeXt101), for automated tumor segmentation and classification. Our approach commences with data acquisition from the BRATS 2020 dataset, a benchmark collection of MRI images with corresponding tumor segmentations. Next, we employ batch normalization to smooth and enhance the collected data, followed by feature extraction using the AlexNet model. This involves extracting features based on tumor shape, position, shape, and surface characteristics. To select the most informative features for effective segmentation, we utilize an advanced meta-heuristics algorithm called Advanced Whale Optimization (AWO). AWO mimics the hunting behavior of humpback whales to iteratively search for the optimal feature subset. With the selected features, we perform image segmentation using the ConvNet-ResNeXt101 model. This deep learning architecture combines the strengths of ConvNet and ResNeXt101, a type of ConvNet with aggregated residual connections. Finally, we apply the same ConvNet-ResNeXt101 model for tumor classification, categorizing the segmented tumor into distinct types. Our experiments demonstrate the superior performance of our proposed ConvNet-ResNeXt101 model compared to existing approaches, achieving an accuracy of 99.27% for the tumor core class with a minimum learning elapsed time of 0.53 s.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.